StockDuty ← Dashboard Oct 01, 2026 09:46 AM ET
SignalCorporate

Recombinant Proteins Manufacturing Services Market Report Released; 19.7% CAGR as revenue nearly triples from $5.2B to $15.3B by 2030; benchmark WuXi Biologics, GenScript, Bio-Rad, ACROBiosystems and

19.7% CAGR with revenue tripling to $15.3B by 2030 drives market significance.

19.7% CAGR with revenue tripling to $15.3B by 2030 drives market significance.
19.7% CAGR with revenue tripling to $15.3B by 2030 drives market significance. — impact context not separately stored; see What changed.
Sources